Company OptiBiotix Health Plc

Equities

OPTI

GB00BP0RTP38

Biotechnology & Medical Research

Business Summary

Managers

Members of the board

Share class

Shareholders

Holdings

Company contact information

Sector

Annual profits - Rate of surprise

Sector Bio Therapeutic Drugs

Market Closed - London S.E. Other stock markets 09:05:29 03/05/2024 pm IST			5-day change	1st Jan Change
18 ^GBX	0.00%		+1.41%	-32.71%

30/04	EARNINGS AND TRADING: Card Factory profit climbs; Pebble "consistent"	AN
25/03	OptiBiotix Health raises GBP1.4 million to invest in "driving sales"	AN

OptiBiotix Health Plc is a United Kingdom-based life sciences company. The Company is primarily engaged in identifying and developing microbial strains, compounds and formulations for use in the nutraceutical industry segment. Its technology platforms include OcptiBiome, OptiScreen and OptiBiotic. Its OptiBiome technology platform that screens identifies and/or develops microbiome modulators, which can be used in formulations to prevent, manage and a range of chronic lifestyle diseases. The OptiScreen pharmaceutical screening platform to identify microbial metabolic pathways that interact with human pathways to improve health. The OptiBiotic platform generates oligosaccharides and screens them for their ability to modulate specific microbial genera or species and their microbial end products (short chain fatty acids, such as acetate, propionate, butyrate) and physical properties (sweetness). Its products include SlimBiome, SweetBiotix, CholBiomeX3, SlimBiome Medical and WellBiome.

Number of employees: 9

Managers	Title	Age	Since
Stephen O'Hara FOU	Founder	64	19/06/19
Graham Lloyd Myers DFI	Director of Finance/CFO	61	01/12
Sofia Kolyda BRD	Director/Board Member	-	18/14/18
Karl Burkitt SAM	Sales & Marketing	-	01/22/01
Zac Sniderman PRN	Corporate Officer/Principal	-	01/22/01
Shiraz Butt PRN	Corporate Officer/Principal	-	01/22/01
Steven Riley SAM	Sales & Marketing	-	02/18/02
Mark Collingbourne SEC	Corporate Secretary	55	-

Members of the board	Title	Age	Since
Richard Davidson CHM	Chairman	72	01/18/01
Sean Christie BRD	Director/Board Member	66	10/18/10
Stephen O'Hara FOU	Founder	64	19/06/19
Sofia Kolyda BRD	Director/Board Member	-	18/14/18

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	97,943,161	85,661,838 ( 87.46 %)	0	87.46 %

Name	Equities	%	Valuation
KW Investment Management Ltd. 11.22 %	10,228,000	11.22 %	3 M p
Stephen O'Hara 11.20 %	10,212,986	11.20 %	3 M p
Mercia Fund Management Ltd. 6.265 %	5,713,314	6.265 %	1 M p
Hargreaves Lansdown Asset Management Ltd. 5.134 %	4,682,000	5.134 %	1 M p
Jarvis Investment Management Ltd. 1.873 %	1,708,000	1.873 %	422 901 p
IG Markets Ltd. 1.760 %	1,605,000	1.760 %	397 398 p
HSBC Global Asset Management (UK) Ltd. 1.673 %	1,526,000	1.673 %	377 838 p
Rathbones Investment Management Ltd. 0.5746 %	524,000	0.5746 %	129 742 p
Richard Davidson 0.5516 %	503,000	0.5516 %	124 543 p
iDealing.com Ltd. 0.4233 %	386,000	0.4233 %	95 574 p

Name	Equities	%	Valuation
SKINBIOTHERAPEUTICS PLC 12.94%	24,940,639	12.94%	4,016,939 $
SKINBIOTHERAPEUTICS PLC 44.00%	53,533,333	44.00%	3,722,708 $

Optibiotix Health Plc

Innovation Centre Innovation Way

YO10 5DG, Heslington

http://www.optibiotix.com

Company calendar

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Bio Therapeutic Drugs

	1st Jan change	Capi.
OPTIBIOTIX HEALTH PLC	-32.71%	22.13M
REGENERON PHARMACEUTICALS, INC.	+8.96%	105B
VERTEX PHARMACEUTICALS INCORPORATED	-1.43%	104B
ARGENX SE	+4.40%	22.94B
BIONTECH SE	-12.15%	22.34B
GENMAB A/S	-4.36%	19.25B
WUXI APPTEC CO., LTD.	-39.98%	17.08B
BEIGENE, LTD.	-10.04%	16.96B
NEUROCRINE BIOSCIENCES, INC.	+6.79%	14.16B
SAREPTA THERAPEUTICS, INC.	+38.61%	12.63B

Bio Therapeutic Drugs